CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Treatment +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02504762
NCT02504762N/ACompleted
CompareCT.gov

HYbrid CoronAry Revascularization in DiabeticS: A Randomized Controlled Trial (Pilot)

Ottawa Heart Institute Research Corporation·interventional·Posted Jul 22, 2015·Updated Jan 22, 2020

In Brief

A clinical study evaluating Treatment and Control for Diabetes and Heart Disease. Completed, enrolled 20 participants across 1 site.

Detailed Summary

To evaluate whether an HCR strategy is more or less effective than conventional coronary artery bypass grafting (cCABG), in diabetic patients with multivessel CAD involving the left anterior descending artery (LAD), who do not present in the context of acute ST-elevation myocardial infarction (STEMI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Heart Disease
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 22, 2015
Enrollment StartAug 1, 2015
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 10.9 years ago

Interventions

Treatmentprocedure

Hybrid Coronary Intervention = MICS CABG + Percutaneous Coronary Intervention. This study is a surgical intervention, which does not involve a drug or device intervention.

Controlprocedure

Conventional CABG. This study is a surgical intervention, which does not involve a drug or device intervention.